Drug correction of endothelial dysfunction in children with chronic pyelonephritis
Journal Title: Здоров`я дитини - Year 2018, Vol 13, Issue 7
Abstract
Background. Timely and sufficient drug correction of endothelial dysfunction in children with chronic pyelonephritis determines the effectiveness of preventing its progression, improves cardiovascular and renal prognosis. The purpose of the study was to examine the effectiveness of various regimens of drug correction for endothelial dysfunction in children with chronic pyelonephritis. Materials and methods. Thirty seven children aged 11–17 years with non-acute chronic pyelonephritis were examined. Thus, the first group of 17 patients received baseline therapy of chronic pyelonephritis, including angiotensin-converting enzyme (ACE) inhibitor enalapril; the second group of 20 patients in addition to standard therapy with ACE inhibitor received the intravenous infusion of L-arginine and then took its oral solution. Results. Patients in the first group had a tendency to increase in the diameter of the brachial artery at rest (2.4 ± 0.1 mm), in the phase of maximal vasodilation (2.9 ± 0.1 mm), without a significant difference from the state before the treatment. An increment of the brachial artery diameter after the treatment had significantly increased in comparison with the level before the treatment (12.00 ± 0.39 mm). Moreover, the reduction of linear blood flow velocity at rest was not statistically significant (146.90 ± 1.13 cm/s). In the second group, there was a significant increase in the brachial artery diameter at rest (2.80 ± 0.13 mm) and in the phase of maximal vasodilation (3.40 ± 0.14 mm) as compared to the baseline. Meanwhile, an increase in the brachial artery diameter after treatment was not significantly different from the physiological norm (17.20 ± 0.41 mm). The linear blood flow velocity at rest was close to the value in the control group, with no significant difference (141.20 ± 1.16 cm/s). In general, the manifestations of endothelial dysfunction decreased by 26.9 and 47.8 % in the first and second groups, respectively. Conclusions. In patients with chronic pyelonephritis without manifestations of chronic renal failure, monotherapy with ACE inhibitor enalapril is effective. In patients with manifestations of chronic renal failure degree I–II, it is advisable to use combined therapy with L-arginine.
Authors and Affiliations
L. I. Vakulenko
Keywords
Related Articles
- EP ID EP423720
- DOI 10.22141/2224-0551.13.7.2018.148919
- Views 103
- Downloads 0
A Child Died of What he Was Treated For, But…
This article describes atypical clinical case of Reye syndrome in 10-year-old girl, appeared on the background of acute enteric infection, and led to death. On the basis of clinical and laboratory data, was well as medic...
Basic Aspects of Studying Risk Factors for Respiratory Diseases in Infants and Preschool Children
The represented review of literature enabled to identify the main factors influencing the development of diseases in infants and preschool children. Knowledge of the various risk factors that contribute to the developme...
World experience on the treatment of interstitial diseases of the lungs in children (up-date 2017)
The article shows modern principles of classification, diagnosis and treatment of interstitial lung diseases in children for the practice of pediatricians, family doctors, pediatric pulmonologists, thoracic surgeons, tra...
Stevens-Johnson syndrome in an adolescent: diagnosis and treatment (clinical case)
The authors present a clinical case of Stevens-Johnson syndrome in an adolescent, a resident of Ternopil region, who was hospitalized in the intensive care unit of Ternopil Regional Children’s Clinical Hospital. The feat...
Nasopharynx Recurrent Disease Prevention in Children with Lymphopharyngeal Ring Hyperplasia
Bsckground. Nasopharyngeal lymphoid tissue is one of the places of accumulation and growth of respiratory disease pathogens. The most vulnerable for them are the children of preschool age with lymphopharyngeal ring hyper...